Other OTC - Delayed Quote USD

Genfit S.A. (GNFTF)

2.9500 0.0000 (0.00%)
At close: April 15 at 12:25 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for GNFTF

Recent News: GNFTF

View More

GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
GlobeNewswire yesterday

GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
GlobeNewswire 11 days ago

GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F
GlobeNewswire 21 days ago

GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 22 days ago

GENFIT Announces Revenues and Cash Position as of December 31, 2023
GlobeNewswire last month

GENFIT Announces 2024 Financial Calendar
GlobeNewswire 3 months ago
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GlobeNewswire 3 months ago

GENFIT Updates 2024 Outlook Following Acceptance of Elafibranor Filings in Primary Biliary Cholangitis (PBC)
GlobeNewswire 4 months ago

Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
GlobeNewswire 4 months ago

GENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+™ as a Screening Tool for the Enrollment of Patients in MASH Clinical Trials
GlobeNewswire 4 months ago

GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
GlobeNewswire 5 months ago

GENFIT: Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
GlobeNewswire 5 months ago
View More

Related Tickers

GLSHQ Gelesis Holdings, Inc.
0.0198
0.00%
 
LOBEF Lobe Sciences Ltd.
0.0150
+2.74%
 
CLGN CollPlant Biotechnologies Ltd.
5.89
+7.48%
 
SRZN Surrozen, Inc.
8.98
+4.30%
 
PHIO Phio Pharmaceuticals Corp.
0.6820
+1.34%
 
VCNX Vaccinex, Inc.
5.83
-1.02%
 
GLMD Galmed Pharmaceuticals Ltd.
0.3916
+0.90%
 
NRSN NeuroSense Therapeutics Ltd.
1.2300
-2.38%
 
ENLV Enlivex Therapeutics Ltd.
1.4400
-0.69%
 
ADIL Adial Pharmaceuticals, Inc.
1.6100
-6.94%